| Literature DB >> 29431637 |
Tonya C Walser1,2,3, Zhe Jing1,2,3, Linh M Tran1,2,3, Ying Q Lin1,2,3, Natalie Yakobian1,2,3, Gerald Wang1,2,3, Kostyantyn Krysan1,2,3, Li X Zhu1,2,3,4, Sherven Sharma1,2,3,4, Mi-Heon Lee5, John A Belperio1,2,3, Aik T Ooi3,6,7, Brigitte N Gomperts3,6,7, Jerry W Shay8, Jill E Larsen9, John D Minna10, Long-Sheng Hong11, Michael C Fishbein11, Steven M Dubinett12,2,3,4,11,13.
Abstract
Epithelial-to-mesenchymal transition (EMT) is organized in cancer cells by a set of key transcription factors, but the significance of this process is still debated, including in non-small cell lung cancer (NSCLC). Here, we report increased expression of the EMT-inducing transcription factor Snail in premalignant pulmonary lesions, relative to histologically normal pulmonary epithelium. In immortalized human pulmonary epithelial cells and isogenic derivatives, we documented Snail-dependent anchorage-independent growth in vitro and primary tumor growth and metastatic behavior in vivo Snail-mediated transformation relied upon silencing of the tumor-suppressive RNA splicing regulatory protein ESRP1. In clinical specimens of NSCLC, ESRP1 loss was documented in Snail-expressing premalignant pulmonary lesions. Mechanistic investigations showed that Snail drives malignant progression in an ALDH+CD44+CD24- pulmonary stem cell subset in which ESRP1 and stemness-repressing microRNAs are inhibited. Collectively, our results show how ESRP1 loss is a critical event in lung carcinogenesis, and they identify new candidate directions for targeted therapy of NSCLC.Significance: This study defines a Snail-ESRP1 cancer axis that is crucial for human lung carcinogenesis, with implications for new intervention strategies and translational opportunities. Cancer Res; 78(8); 1986-99. ©2018 AACR. ©2018 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29431637 PMCID: PMC5899686 DOI: 10.1158/0008-5472.CAN-17-0315
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701